| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $158.3M | +1031.2% |
| R&D Expense | $39.3M | -17.9% |
| SG&A Expense | $157.2M | +92.7% |
| Operating Income | -$51.4M | +57.6% |
| Income Tax | $0 | — |
| Net Income | -$68.9M | +47.1% |
| EPS (Basic) | -$0.80 | +51.8% |
| EPS (Diluted) | -$0.80 | +51.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $190.7M | +8.0% |
| Accounts Receivable | $54.1M | +1889.4% |
| Inventory | $23.8M | +9776.3% |
| Current Assets | $273.4M | +47.7% |
| Total Assets | $327.9M | +42.4% |
| Current Liabilities | $135.8M | +225.0% |
| Total Liabilities | $283.2M | +85.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$35.7M | +61.8% |
| Capital Expenditures | $4.3M | -12.4% |
| Investing Cash Flow | -$6.3M | +24.9% |
| Financing Cash Flow | $59.7M | -69.3% |
| Free Cash Flow | -$40.0M | +59.3% |
| Stockholders' Equity |
| $44.7M |
| -42.1% |